Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;11(2):206–217. doi: 10.1111/j.1750-3639.2001.tb00393.x

Congenital Myopathies

Antje Bornemann 1,✉, Hans H Goebel 2
PMCID: PMC8098536  PMID: 11303796

Abstract

Most congenital myopathies have been defined on account of the morphological findings in enzyme histochemical preparations. In effect, the diagnosis of this group of diseases continues to be made on the histological pattern of muscle biopsies. However, progress has been made in elucidating the molecular genetic background of several of the congenital myopathies. In this updated review we address those congenital myopathies for which gene defects and mutant proteins have been found (central core disease, nemaline myopathies, desminopathy, actinopathy, certain vacuolar myopathies, and myotubular myopathy) and the other disease with central nuclei (centronuclear myopathy).

Full Text

The Full Text of this article is available as a PDF (714.7 KB).

References

  • 1. Akiyama C, Nonaka I (1996) A follow‐up study of congenital non‐progressive myopathies. Brain Dev 18:404–408. [DOI] [PubMed] [Google Scholar]
  • 2. Auranen M, Villanova M, Muntoni F, Fardeau M, Scherer SW, Kalimo H, Minassian BA (2000) X‐linked vacuolar myopathies: two separate loci and refined genetic mapping. Ann Neurol 47: 666–669. [PubMed] [Google Scholar]
  • 3. Barohn RJ, Brumback RA, Mendell JR (1994) Hyaline body myopathy. Neuromusc Disord 4: 257–262. [DOI] [PubMed] [Google Scholar]
  • 4. Bilak M, Askanas V, Engel WK (1993) Strong immunoreactivity of alpha1‐antichymotrypsin co‐localizes with beta‐amyloid protein and ubiquitin in vacuolated muscle fibres of inclusion‐body myositis. Acta Neuropathol (Berl) 85: 378–382. [DOI] [PubMed] [Google Scholar]
  • 5. Blondeau F, Laporte J, Bodin S, Superti‐Furga G, Payrastre B, Mandel JL (2000) Myotubularin, a phosphatase deficient in myotubular myopathy, acts on PI 3‐kinase and phosphatidylinositol 3 phosphate pathway. Hum Mol Genet 9:2223–2229. [DOI] [PubMed] [Google Scholar]
  • 6. Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MAM, Georgiou DM, Christodoulou K, Hausmanowa‐Petrusewicz I, Mandich P, Schenone A, Gambardella A, Bono F, Quattrone A, Devoto M, Monaco AP (2000) Charcot‐Marie‐Tooth type 4B is caused by mutations in the gene encoding myotubularin‐related protein‐2. Nat Genet 25: 17–19. [DOI] [PubMed] [Google Scholar]
  • 7. Bornemann A, Bloch P, Petersen M, Schmalbruch H (1996) Fatal congenital myopathy with actin filament deposits. Acta Neuropathol (Berl) 92: 104–108. [DOI] [PubMed] [Google Scholar]
  • 8. Bourque PR, Lach B, Carpenter S, Rippstein P (1999) Myopathy with hexagonally cross‐linked tubular arrays: a new autosomal dominant or sporadic congenital myopathy. Ann Neurol 45: 512–515. [PubMed] [Google Scholar]
  • 9. Buj‐Bello A, Biancalana V, Moutou C, Laporte J, Mandel JL (1999) Identification of novel mutations in the MTM1 gene causing severe and mild forms of X‐linked myotubular myopathy. Hum Mutat 14:320–325. [DOI] [PubMed] [Google Scholar]
  • 10. Cancilla PA, Kalyanaraman K, Verity MA, Munsat T, Pearson CM (1971) Familial myopathy with probable lysis of myofibrils in type I fibres. Neurology 21: 579–585. [DOI] [PubMed] [Google Scholar]
  • 11. Caron A, Chapon F (1999) Desmin phosphorylated abnormalities in cytoplasmic body and desmin‐related myopathies. Muscle Nerve 22: 1122–1125. [DOI] [PubMed] [Google Scholar]
  • 12. Ceuterick C, Martin J‐J, Martens C (1993) Hyaline bodies in skeletal muscle of a patient with a mild chronic nonprogressive congenital myopathy. Clin Neuropathol 12: 79–83. [PubMed] [Google Scholar]
  • 13. Conen PE, Murphy EG, Donohue WL (1963) Light and electron microscopic studies of “myogranules” in a child with hypotonia and muscle weakness. Can Med Assoc J 89: 983–986. [PMC free article] [PubMed] [Google Scholar]
  • 14. Cui X, De Vivo I, Slany R, Miyamoto A, Firestein R, Cleary MI (1998) Association of SET domain and myotubularin‐related proteins modulates growth control. Nat Genet 18:331–337. [DOI] [PubMed] [Google Scholar]
  • 15. Curran JL, Hall WJ, Halsall PJ, Hopkins PM, Iles DE, Markham AF, McCall SH, Robinson RL, West SP, Bridges LR, Ellis FR (1999) Segregation of malignant hyperthermia, central core disease and chromosome 19 markers. Br J Anaesth 83:217–222. [DOI] [PubMed] [Google Scholar]
  • 16. Dalakas MC, Park K‐Y, Semino‐Mora C, Lee HS, Sivakumar K, Goldfarb LG (2000) Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 342: 770–780. [DOI] [PubMed] [Google Scholar]
  • 17. Danon MJ, Giometti CS, Manaligod JR, Perurena OH, Skosey JL (1981) Adult‐onset nemaline rods in a patient treated for suspected dermatomyositis. Arch Neurol 38: 761–766. [DOI] [PubMed] [Google Scholar]
  • 18. De Bleecker JL, Engel AG, Ertl BB (1996) Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropathol Exp Neurol 55: 563–577. [DOI] [PubMed] [Google Scholar]
  • 19. Donner K, Ollikainen M, Pelin K, Grönholm M, Carpén O, Wallgren‐Pettersson C, Ridanpää M (2000) Mutations in the beta‐tropomyosin (TPM2) gene in rare cases of auto‐somal‐dominant nemaline myopathy. Neuromusc Disord 10: 342 (abstract æ C.O.1). [DOI] [PubMed] [Google Scholar]
  • 20. Dubowitz V (1985) Muscle Biopsy: A Practical Approach, pp. 664–670, Baillière Tindall: London . [Google Scholar]
  • 21. Edström L, Thornell L‐E, Eriksson A (1980) A new type of hereditary distal myopathy with characteristic sarcoplasmic bodies and intermediate (skeletin) filaments. J Neurol Sci 47: 171–190. [DOI] [PubMed] [Google Scholar]
  • 22. Fananapazir L, Dalakas MC, Cyran F, Cohn G, Epstein ND (1993) Missense mutations in the beta‐myosin heavy‐chain gene cause central core disease in hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 90:3993–3997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Fardeau M, Godet‐Guillain J, Tomé FSM, Collin H, Gaudeau S, Boffety C, Vernant P (1978) Une nouvelle affection musculaire familiale, définie par l'accumulation intra‐sarco‐plasmique d'un matériel granulo‐filamentaire dense en microscopie électronique. Rev Neurol (Paris) 134: 411–425. [PubMed] [Google Scholar]
  • 24. Fardeau M, Tomé FMS (1994) Congenital myopathies In: Myology, Engel AG, Franzini‐Armstrong C (eds.), PP. 1487–1532, McGraw‐Hill Inc.: New York . [Google Scholar]
  • 25. Ferreiro A, Estournet B, Chateau D, Romero NB, Laroche C, Odent S, Toutain, Fardeau M (2000) Multi‐minicore disease—searching for boundaries: Phenotype anaylsis of 38 cases. Ann Neurol 48: 745–757. [PubMed] [Google Scholar]
  • 26. Fidzianska A, Goebel HH, Osborn M, Lenard HG, Osse G, Langenbeck U (1983) Mallory body‐like inclusions in a hereditary congenital neuromuscular disease. Muscle Nerve 6: 195–200. [DOI] [PubMed] [Google Scholar]
  • 27. Fidzianska A, Ryniewicz B, Barcikowska M, Goebel HH (1995) A new familial congenital myopathy in children with desmin and dystrophin reacting plaques. J Neurol Sci 131: 88–95. [DOI] [PubMed] [Google Scholar]
  • 28. Forloni G, Bertani I, Calella AM, Thaler F, Invernizzi R (2000) Alpha‐synuclein and Parkinson's disease: selective neurodegenerative effect of alpha‐synuclein fragment on dopaminergic neurons in vitro and in vivo . Ann Neurol 47: 632–640. [PubMed] [Google Scholar]
  • 29. Goebel HH (1997) Desmin‐related myopathies. Curr Opin Neurol 10: 426–429. [DOI] [PubMed] [Google Scholar]
  • 30. Goebel HH, Anderson J (1999) Structural congenital myopathies (excluding nemaline myopathy, myotubular myopathy and desminopathies). 56th European Neuromuscular Centre (ENMC)‐sponsored International Workshop, December 12–14, 1997, Naarden, The Netherlands. Neuromusc Disord 9: 50–57. [DOI] [PubMed] [Google Scholar]
  • 31. Goebel HH, Anderson JR, Hübner C, Oexle K, Warlo I (1997) Congenital myopathy with excess of thin myofilaments. Neuromusc Disord 7: 160–168. [DOI] [PubMed] [Google Scholar]
  • 32. Goebel HH, D'Agostino AN, Wilson J, Cole G, Foroud T, Koller D, Farlow M, Azzarelli B, Muller J (1997) Spheroid body myopathy ‐ revisited. Muscle Nerve 20: 1127–1136. [DOI] [PubMed] [Google Scholar]
  • 33. Goebel HH, Fidzianska A (1996) Classification of congenital myopathies In: Handbook of Muscle Disease, Lane RJM (eds.), pp. chapter 14, pp. 165–176, Marcel Dekker, Inc.: New York . [Google Scholar]
  • 34. Goebel HH, Lenard HG (1992) Congenital myopathies In: Myopathies ‐ Handbook of Clinical Neurology, Rowland LP, DiMauro S (eds.), PP. 331–367, Elsevier Science Publishers B. V.: Amsterdam . [Google Scholar]
  • 35. Goebel HH, Muller J, Gillen HW, Merritt AD (1978) Autosomal dominant “spheroid body myopathy”. Muscle Nerve 1: 14–26. [DOI] [PubMed] [Google Scholar]
  • 36. Goebel HH, Piirsoo A, Warlo I, Schofer O, Kehr S, Gaude M (1997) Infantile intranuclear rod myopathy. J Child Neurol 12: 22–30. [DOI] [PubMed] [Google Scholar]
  • 37. Goebel HH, Voit T, Warlo I, Jacobs K, Johannsen U, Müller CR (1994) Immunohistologic and electron microscopic abnormalities of desmin and dystrophin in familial cardiomyopathy and myopathy. Rev Neurol (Paris) 150: 452–459. [PubMed] [Google Scholar]
  • 38. Goebel HH, Warlo I (1997) Nemaline myopathy with intranuclear rods ‐ intranuclear rod myopathy. Neuromusc Disord 7: 13–19. [DOI] [PubMed] [Google Scholar]
  • 39. Goldfarb LG, Park K‐Y, Cervenáková S, Lee H‐S, Vasconcelos O, Nagle JW, Semino‐Mora C, Sivakumar K, Dalakas MC (1998) Missense mutations in desmin associated with familial cardiac and skeletal myopathy [letter]. Nature Genet 19: 402–403. [DOI] [PubMed] [Google Scholar]
  • 40. Goldfarb LG, Sivakumar K, Park K‐Y, Ferrans VJ, Semino‐Mora C, Litvak S, Takeda K, Dalakas MC (2000) Structural and functional deficiency of desmin associated with cardiac and skeletal myopathy. Neuromusc Disord 10: 383 (abstract L.P.1.5). [Google Scholar]
  • 41. Hart ZH, Servidei S, Peterson PL, Chang C‐H, DiMauro S (1987) Cardiomyopathy, mental retardation, and autophagic vacuolar myopathy. Neurology 37: 1065–1068. [DOI] [PubMed] [Google Scholar]
  • 42. Horowitz SH, Schmalbruch H (1994) Autosomal dominant distal myopathy with desmin storage: a clinicopathologic and electrophysiologic study of a large kinship. Muscle Nerve 17: 151–160. [DOI] [PubMed] [Google Scholar]
  • 43. Kalimo H, Savontaus M‐L, Lang H, Paljärvi L, Sonninen V, Dean PB, Katevuo K, Salminen A (1988) X‐linked myopathy with excessive autophagy: a new hereditary muscle disease. Ann Neurol 23: 258–265. [DOI] [PubMed] [Google Scholar]
  • 44. Laing NG, Knowak K, Durling H, North K, Nonaka I, Hutchinson D, von Kaisenberg C, Muntoni F, Pelin K, Wallgren‐Pettersson C (2000) Actin and nemaline‐related myopathy. Brain Pathol 10: 595 (abstract W02‐03). [Google Scholar]
  • 45. Laing NG, Wilton SD, Akkari PA, Dorosz S, Boundy K, Kneebone C, Blumbergs P, White S, Watkins H, Love DR, Haan E (1995) A mutation in the alpha‐tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nature Genet 9: 75–79. [DOI] [PubMed] [Google Scholar]
  • 46. Lammens M, Moerman P, Fryns JP, Lemmens F, van de Kamp GM, Goemans N, Dom R (1997) Fetal akinesia sequence caused by nemaline myopathy. Neuropediatrics 28: 116–119. [DOI] [PubMed] [Google Scholar]
  • 47. Laporte J, Hu LJ, Kretz C, Mandel JL, Kioschis P, Coy JF, Klauck SM, Poustka A, Dahl N (1996) A gene mutated in X‐linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 13: 175–182. [DOI] [PubMed] [Google Scholar]
  • 48. Laporte J, Biancalana V, Tanner SM, Kress W, Schneider V, Wallgren‐Pettersson C, Herger F, Buj‐Bello A, Blondeau F, Liechti‐Gallati S, Mandel JL (2000) MTM1 mutations in X‐linked myotubular myopathy. Hum Mutat 15:393–409. [DOI] [PubMed] [Google Scholar]
  • 49. Li D, Tapscoft T, Gonzalez O, Burch PE, Quiñones MA, Zoghbi WA, Hill R, Bachinski LL, Mann DL, Roberts R (1999) Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100: 461–464. [DOI] [PubMed] [Google Scholar]
  • 50. Liechti‐Gallati S, Wolff G, Ketelsen UP, Braga S (1993) Prenatal diagnosis of X‐linked centronuclear myopathy by linkage analysis. Pediatr Res 33:201–204. [DOI] [PubMed] [Google Scholar]
  • 51. Lobrinus JA, Janzer RC, Kuntzer T, Matthieu J‐M, Pfend G, Goy J‐J, Bogousslavsky J (1998) Familial cardiomyopathy and distal myopathy with abnormal desmin accumulation and migration. Neuromusc Disord 8: 77–86. [DOI] [PubMed] [Google Scholar]
  • 52. Loke J, McLennan DH (1998) Malignant hyperthermia and central core disease: Disorders of Ca2+ release channels. Am J Med 104:470–486. [DOI] [PubMed] [Google Scholar]
  • 53. Lynch PJ, Tong J, Lehane M, Mallet A, Giblin L, Heffron JJA, Vaughan P, Zafra G, MacLennan DH, McCarthy TV (1999) A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease. Proc Natl Acad Sci USA 96:4164–4169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Manning BM, Quane KA; Ording H, Urwyler A, Tegazzin V, Lehane M, O'halloran J, Hartung E, Giblin LM, Lynch PJ, Vaughan P, Censier K, Bendixen D, Comi G, Heytens L, Monsieurs K, Fagerlund T, Wolz W, Heffron JJA, Muller CR, McCarthy TV (1998) Identification of novel mutations in the ryanodine‐receptor gene (RYR1) in malignant hyperthermia: Genotype‐phenotype correlation. Am J Hum Genet 62:599–609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Masuzugawa S, Kuzuhara S, Narita Y, Naito Y, Taniguchi A, Ibi T (1997) Autosomal dominant hyaline body myopathy presenting as scapuloperoneal syndrome: clinical features and muscle pathology. Neurology 48: 253–257. [DOI] [PubMed] [Google Scholar]
  • 56. McCarthy TV, Quane KA, Lynch PJ (2000) Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum Mutat 15:410–417. [DOI] [PubMed] [Google Scholar]
  • 57. Melberg A, Oldfors A, Blomström‐Lundqvist C, Stålberg E, Carlsson B, Larsson E, Lidell C, Eeg‐Olofsson KE, G. W, Henriksson , Dahl N (1999) Autosomal dominant myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy linked to chromosome 10q. Ann Neurol 46: 684–692. [DOI] [PubMed] [Google Scholar]
  • 58. Messing A, Johnson AB, Boespflug‐Tanguy O, Rodriguez D, Goldman JE, Brenner M (2000) Mutations in the GFAP associated with Alexander disease. J Neuropathol Exp Neurol 59: 455 (abstract æ 143). [Google Scholar]
  • 59. Misra AK, Menon NK, Mishra SK (1992) Abnormal distribution of desmin and vimentin in myofibers in adult onset myotubular myopathy. Muscle Nerve 15: 1246–1252. [DOI] [PubMed] [Google Scholar]
  • 60. Muñoz‐Mármol AM, Strasser G, Isamat M, Coulombe PA, Yang Y, Roca X, Vela E, Mate JL, Coll J, Fernández‐Figueras MT, Navas‐Palacios J, Ariza A, Fuchs E (1998) A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc Natl Acad Sci USA 95: 11312–11317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Muntoni F, Catani G, Mateddu A, Rimoldi M, Congiu T, Faa G, Marrosu MG, Cianchetti C, Porcu M (1994) Familial cardiomyopathy, mental retardation and myopathy associated wtih desmin‐type intermediate filaments. Neuromusc Disord 4: 233–241. [DOI] [PubMed] [Google Scholar]
  • 62. Nakano S, Engel AG, Waclawik AJ, Emslie‐Smith AM, Busis NA (1996) Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron microscopy analysis of 10 cases. J Neuropathol Exp Neurol 55: 549–562. [DOI] [PubMed] [Google Scholar]
  • 63. Nishino I, Fu J, Tanji K, Sue CM, Shanske S, Bonilla E, Nonaka I, DiMauro S, Hirano M (2000) Primary LAMP‐2 deficiency causes vacuolar cardiomyopathy, myopathy, and mental retardation (Danon's disease). Neuromusc Disord 10: 377 (abstract: G. O. 6). [Google Scholar]
  • 64. North KN, Laing NG, Wallgren‐Pettersson C, ENMC International Consortium on Nemaline Myopathy (1997) Nemaline myopathy: current concepts. J Med Genet 34: 705–713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Nowak KJ, Wattanasirichaigoon D, Goebel HH, Wilce M, Pelin K, Donner K, Jacob RL, Hübner C, Oexle K, Anderson JR, Verity CM, North KN, Iannaccone ST, Müller CR, Nürnberg P, Muntoni F, Sewry C, Hughes R, Sutphen R, Lacson AG, Swoboda KJ, Vigneron J, Wallgren‐Pettersson C, Beggs AH, Laing AH (1999) Mutations in the skeletal muscle alpha‐actin gene in patients with actin myopathy and nemaline myopathy. Nature Genet 23: 208–212. [DOI] [PubMed] [Google Scholar]
  • 66. Osborn M, Goebel HH (1983) The cytoplasmic bodies in a congenital myopathy can be stained with antibodies to desmin, the muscle‐specific intermediate filament protein. Acta Neuropathol (Berl) 62: 149–152. [DOI] [PubMed] [Google Scholar]
  • 67. Park KY, Dalakas MC, Goebel HH, Ferrans VJ, Semino‐Mora C, Litvak S, Takeda K, Goldfarb LG (2000) Desmin splice variants causing cardiac and skeletal myopathy. J Med Genet 37: 851 (abstract). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Pelin K, Hipelä P, Sewry C, Akkari PA, Wilton SD, Wattanasirichaigoon D, Bang M‐L, Centner T, Hanefeld F, Odent S, Fardeau M, Utizberea JA, Muntoni F, Dubowitz V, Beggs AH, Laing NG, Labeit S, de la Chapelle A, Wallgren‐Petterson C (1999) Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci USA 96: 2305–2310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Phillips MS, Fujii J, Khanna VK, DeLeon S, Yokobata K, De Jong PJ, MacLennan DH (1996) The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. Genomics 34:24–41. [DOI] [PubMed] [Google Scholar]
  • 70. Rappaport L, Contard F, Samuel JL, Delcayre C, Marotte F, Tomé F, Fardeau M (1988) Storage of phosphorylated desmin in a familial myopathy. FEBS Lett 231: 421–425. [DOI] [PubMed] [Google Scholar]
  • 71. Riggs JE, Schochet SS, Gutmann L, Shanske S, Neal WA, DiMauro S (1983) Lysosomal glycogen storage disease without acid maltase deficiency. Neurology 33: 873–877. [DOI] [PubMed] [Google Scholar]
  • 72. Saavedra‐Matiz CA, Chapman NH, Wijsman EM, Horowitz SH, Rosen DR (1999) Linkage of hereditary distal myopathy with desmin accumulation to 2q. Hum Hered 50: 166–170. [DOI] [PubMed] [Google Scholar]
  • 73. Sarnat HB (1990) Myotubular myopathy: arrest of morphogenesis of myofibres associated with persistence of fetal vimentin and desmin. Can J Neurol Sci 17: 109–123. [DOI] [PubMed] [Google Scholar]
  • 74. Schell C, Kan A, North KN (2000) An artefact gone awry: Identification of the first case of nemaline myopathy by Dr. R. D. K. Reye. Neuromusc Disord 10: 307–312. [DOI] [PubMed] [Google Scholar]
  • 75. Shuaib A, Paasuke RT, Brownell KW (1987) Central core disease. Clinical features in 13 patients. Medicine Baltimore 66:389–396. [PubMed] [Google Scholar]
  • 76. Shy GM, Engel WK, Somers JE, Wanko T (1963) Nemaline myopathy. A new congenital myopathy. Brain 79: 793–810. [DOI] [PubMed] [Google Scholar]
  • 77. Sjöberg G, Saavedra‐Matiz CA, Rosen DR, Wijsman EM, Borg K, Horowitz SH, Sejersen T (1999) A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum Mol Genet 8: 2191–2198. [DOI] [PubMed] [Google Scholar]
  • 78. Skyllouriotis ML, Marx M, Skyllouriotis P, Bittner R, Wimmer M (1997) Nemaline myopathy and cardiomyopathy. Pediatr Neurol 20: 319–321. [DOI] [PubMed] [Google Scholar]
  • 79. Spiro AJ, Shy GM, Gonatas NK (1966) Myotubular myopathy. Persistence of fetal muscle in an adolescent boy. Arch Neurol 14: 1–14. [DOI] [PubMed] [Google Scholar]
  • 80. Tan P, Briner J, Boltshauer E, Davis MR, Wilton SD, North K, Wallgren‐Pettersson C, Laing NG (1999) Homozygosity for a nonsense mutation in the alpha‐tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy. Neuromusc Disord 9: 573–579. [DOI] [PubMed] [Google Scholar]
  • 81. Tanner SM, Laporte J, Guiraud‐Chaumeil C, Liechti‐Gallati S (1998) Confirmation of prenatal diagnosis results of X‐linked recessive myotubular myopathy by mutational screening, and description of three new mutations in the MTM1 gene. Human Mutat 11:62–68. [DOI] [PubMed] [Google Scholar]
  • 82. Tanner SM, Schneider V, Thomas NST, Clarke A, Lazarou L, Liechti‐Gallati S (1999) Characterization of 34 novel and six known MTM1 gene mutations in 47 unrelated X‐linked myotubular myopathy patients. Neuromusc Disord 9:41–49. [DOI] [PubMed] [Google Scholar]
  • 83. Taylor GS, Maehama T, Dixon JE (2000) Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3‐phosphate. Proc Natl Acad Sci USA 97:8910–8915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84. Usuki F, Takenaga S, Higuchi I, Kashio N, Nakagawa M, Osame M (1994) Morphologic findings in biopsied skeletal muscle and cultured fibroblasts from a female patient with Danon's disease (lysosomal glycogen storage disease without acid maltase deficiency). J Neurol Sci 127: 54–60. [DOI] [PubMed] [Google Scholar]
  • 85. van der Ven PF, Jap PH, Barth PG, Sengers RC, Ramaekers FC, Stadhouders AM (1995) Abnormal expression of intermediate filament proteins in X‐linked myotubular myopathy is not reproduced in vitro. Neuromusc Disord 5:267–275. [DOI] [PubMed] [Google Scholar]
  • 86. Vicart P, Dupret J‐M, Hazan J, Li Z, Gyapay G, Krishnamoorthy R, Weissenbach J, Fardeau M, Paulin D (1996) Human desmin gene: cDNA sequence, regional localization and exclusion of the locus in a familial desmin‐related myopathy. Human Genetics 98: 422–429. [DOI] [PubMed] [Google Scholar]
  • 87. Villanova M, Louboutin JP, Chateau D, Eymard B, Sagniez M, Tomé MS, Fardeau M (1995) X‐linked vacuo‐lated myopathy: complement membrane attack complex on surface membrane of injured muscle fibers. Ann Neurol 37: 637–645. [DOI] [PubMed] [Google Scholar]
  • 88. Villard L, des Portes V, Levy N, Louboutin J‐P, Recan D, Coquet M, Chabrol B, Figarella‐Branger D, Chelly J, Pellissier J‐F, Fontes M (2000) Linkage of X‐linked myopathy with excessive autophagy (XMEA) to Xq28. Eur J Hum Genet 8: 125–129. [DOI] [PubMed] [Google Scholar]
  • 89. Wallgren‐Pettersson C, Beggs AH, Laing NG (1998) Nemaline myopathy. 51 st European Neuromuscular Centre (ENMC)‐sponsored International Workshop, 13–15 June 1997, Naarden, The Netherlands. Neuromusc Disord 8: 53–56. [PubMed] [Google Scholar]
  • 90. Wallgren‐Pettersson C, Laing NG (1996) Nemaline Myopathy. 40th European Neuromuscular Centre (ENMC)‐sponsored International Workshop, 2–4 February 1996, Naarden, The Netherlands. Neuromusc Disord 6: 389–391. [DOI] [PubMed] [Google Scholar]
  • 91. Wallgren‐Pettersson C, Pelin K, Hilpelä P, Donner K, Porfirio B, Graziano C, Swoboda KJ, Fardeau M, Urtizberea JA, Muntoni F, Sewry C, Dubowitz V, Iannaccone ST, Minetti C, Pedemonte M, Seri M, Cusano R, Lammens M, Castagna‐Sloane A, Beggs AH, Laing NG, de la Chapelle A (1999) Clinical and genetic heterogeneity in autosomal recessive nemaline myopathy. Neuromusc Disord 9: 564–572. [DOI] [PubMed] [Google Scholar]
  • 92. Wilhelmsen KC, Blake DM, Lynch T, Mabutas J, De Vera M, Neystat M, Bernstein M, Hirano M, Gilliam TC, Murphy PL, Sola MD, Bonilla E, Schotland DL, Hays AP, Rowland LP (1996) Chromosome 12‐linked autosomal dominant scapuloperoneal muscular dystrophy. Ann Neurol 39: 507–520. [DOI] [PubMed] [Google Scholar]
  • 93. Wöckel L, Ketelsen UP, Stötter M, Laule S, Meyermann R, Bornemann A (1998) Abundant minute myotubes in a patient who later developed centronuclear myopathy. Acta Neuropathol 95:547–551. [DOI] [PubMed] [Google Scholar]
  • 94. Xiang F, Nicolao P, Chapon F, Edström L, Anvret M, Zhang Z (1999) A second locus for autosomal dominant myopathy with proximal muscle weakness and early respiratory muscle involvement: a likely chromosomal locus on 2q21. Neuromusc Disord 9: 308–312. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES